DE3584209D1 - T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide. - Google Patents

T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide.

Info

Publication number
DE3584209D1
DE3584209D1 DE3584209T DE3584209T DE3584209D1 DE 3584209 D1 DE3584209 D1 DE 3584209D1 DE 3584209 T DE3584209 T DE 3584209T DE 3584209 T DE3584209 T DE 3584209T DE 3584209 D1 DE3584209 D1 DE 3584209D1
Authority
DE
Germany
Prior art keywords
coding
specific
antigen receptor
cell receptor
cell antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3584209T
Other languages
English (en)
Other versions
DE3584209T2 (de
Inventor
Mark Davis
Stephen Hedrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27079355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3584209(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of DE3584209D1 publication Critical patent/DE3584209D1/de
Application granted granted Critical
Publication of DE3584209T2 publication Critical patent/DE3584209T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DE3584209T 1984-03-01 1985-02-28 T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide. Expired - Lifetime DE3584209T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58533384A 1984-03-01 1984-03-01
US66380984A 1984-10-22 1984-10-22
PCT/US1985/000367 WO1985003947A1 (en) 1984-03-01 1985-02-28 T-cell receptor-specific for antigen polypeptides and related polynucleotides

Publications (2)

Publication Number Publication Date
DE3584209D1 true DE3584209D1 (de) 1994-12-01
DE3584209T2 DE3584209T2 (de) 1995-05-04

Family

ID=27079355

Family Applications (3)

Application Number Title Priority Date Filing Date
DE3588219T Expired - Lifetime DE3588219T2 (de) 1984-03-01 1985-02-28 T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
DE0570027T Pending DE570027T1 (de) 1984-03-01 1985-02-28 T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide.
DE3584209T Expired - Lifetime DE3584209T2 (de) 1984-03-01 1985-02-28 T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE3588219T Expired - Lifetime DE3588219T2 (de) 1984-03-01 1985-02-28 T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
DE0570027T Pending DE570027T1 (de) 1984-03-01 1985-02-28 T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide.

Country Status (8)

Country Link
US (3) US5316925A (de)
EP (3) EP0174366B1 (de)
JP (7) JPH06225765A (de)
AT (1) ATE188251T1 (de)
DE (3) DE3588219T2 (de)
HK (2) HK1006855A1 (de)
SG (1) SG70553A1 (de)
WO (1) WO1985003947A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713332A (en) * 1984-01-13 1987-12-15 The Ontario Cancer Institute T cell specific CDNA clone
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor
EP0174366B1 (de) 1984-03-01 1994-10-26 The Board Of Trustees Of The Leland Stanford Junior University T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide
US4874845A (en) * 1984-06-13 1989-10-17 Massachusetts Institute Of Technology T lymphocyte receptor subunit
US5189147A (en) * 1984-06-13 1993-02-23 Massachusetts Institute Of Technology Meterodimeric T lymphocyte receptor antibody
ES2093606T3 (es) * 1987-06-23 1997-01-01 Univ Leland Stanford Junior Gen del receptor de celulas t localizado en el locus alfa y estructuras artificiales de adn.
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
US6710169B2 (en) 1987-10-02 2004-03-23 Genentech, Inc. Adheson variants
US6413516B1 (en) * 1989-03-21 2002-07-02 The Immune Response Corporation Peptides and methods against psoriasis
US6464978B1 (en) 1989-03-21 2002-10-15 The Immune Response Corporation Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
US5776459A (en) * 1989-07-19 1998-07-07 Connetics Corporation TCR V beta 5 peptides
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
US6416971B1 (en) * 1990-05-15 2002-07-09 E.R. Squibb & Sons, Inc. Soluble single chain T cell receptors
US7294712B2 (en) * 1990-06-04 2007-11-13 Aventis Pharma S.A. Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
KR100227303B1 (ko) * 1991-02-12 1999-12-01 장-끌로드 비에이으포스 인체 t 임파구 수용체의 베타 사슬의 가변성 영역을 코딩하는 뉴클레오티드 서열, 대응하는 펩티드 세그먼트 및 진단 및 치료 용도
US5552300A (en) * 1994-01-13 1996-09-03 T Cell Sciences, Inc. T cell antigen receptor V region proteins and methods of preparation thereof
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
US5688690A (en) * 1994-09-16 1997-11-18 The Wistar Institute Of Anatomy And Biology Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto
US6087096A (en) * 1995-11-13 2000-07-11 Dau; Peter C. Method of intrafamily fragment analysis of the T cell receptor α and β chain CDR3 regions
EP1029918A4 (de) 1997-09-26 2003-01-02 Kyowa Hakko Kogyo Kk Rezeptor von tötenden t-zellen, die den menschlichen immunodefizienz virus erkennen
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
DE19816129A1 (de) * 1998-04-09 1999-10-14 Dolores Schendel T-Zellrezeptor-Expressionskassette
US20020165149A1 (en) * 2000-12-08 2002-11-07 Kranz David M. Mutated class II major histocompatibility proteins
DE10109855A1 (de) * 2001-03-01 2002-09-12 Stanislawski Thomas Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung
US20030199092A1 (en) * 2002-01-11 2003-10-23 The Regents Of The University Of California Methods for increasing mRNA half-life in eukaryotic cells
CN101098891B (zh) 2005-01-05 2014-05-21 F-星生物技术研究与开发有限公司 分子中互补决定区以外的区域中工程改造了的具有结合特性的合成免疫球蛋白结构域
US20080064631A1 (en) * 2006-01-13 2008-03-13 Jeffrey Molldrem T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease
AT503889B1 (de) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F Multivalente immunglobuline
US10155038B2 (en) 2007-02-02 2018-12-18 Yale University Cells prepared by transient transfection and methods of use thereof
US9249423B2 (en) 2007-02-02 2016-02-02 Yale University Method of de-differentiating and re-differentiating somatic cells using RNA
WO2008097926A2 (en) * 2007-02-02 2008-08-14 Yale University Transient transfection with rna
WO2009045898A2 (en) * 2007-09-28 2009-04-09 Mayo Foundation For Medical Education And Research Assessing t cell repertoires
EP2098536A1 (de) 2008-03-05 2009-09-09 4-Antibody AG Isolation und Identifikation antigen- oder ligandenspezifischer Bindungsproteine
EP2113255A1 (de) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Zytotoxisches Immunglobulin
JP5829606B2 (ja) * 2009-06-29 2015-12-09 カリフォルニア・インスティテュート・オブ・テクノロジーＣａｌｉｆｏｒｎｉａ Ｉｎｓｔｉｔｕｔｅ Ｏｆｔｅｃｈｎｏｌｏｇｙ 単一細胞からの未知の再配列されたｔ細胞受容体の単離
US10526391B2 (en) 2014-07-22 2020-01-07 The University Of Notre Dame Du Lac Molecular constructs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468464A (en) * 1974-11-04 1984-08-28 The Board Of Trustees Of The Leland Stanford Junior University Biologically functional molecular chimeras
US4363877B1 (en) * 1977-09-23 1998-05-26 Univ California Recombinant dna transfer vectors
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
US4394443A (en) * 1980-12-18 1983-07-19 Yale University Method for cloning genes
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4713332A (en) * 1984-01-13 1987-12-15 The Ontario Cancer Institute T cell specific CDNA clone
US4923799A (en) * 1984-02-06 1990-05-08 The Ontario Cancer Institute T cell specific cDNA clone
EP0174366B1 (de) * 1984-03-01 1994-10-26 The Board Of Trustees Of The Leland Stanford Junior University T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide
US4874845A (en) * 1984-06-13 1989-10-17 Massachusetts Institute Of Technology T lymphocyte receptor subunit
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor

Also Published As

Publication number Publication date
ATE188251T1 (de) 2000-01-15
JPH07274976A (ja) 1995-10-24
EP0174366A1 (de) 1986-03-19
JPH1067675A (ja) 1998-03-10
DE570027T1 (de) 1994-11-17
WO1985003947A1 (en) 1985-09-12
JPH09121871A (ja) 1997-05-13
EP0174366B1 (de) 1994-10-26
US6180104B1 (en) 2001-01-30
HK1013844A1 (en) 1999-09-10
DE3588219T2 (de) 2000-05-18
EP0174366A4 (de) 1987-03-26
EP0570027B1 (de) 1999-12-29
SG70553A1 (en) 2000-02-22
EP0609901A1 (de) 1994-08-10
US5316925A (en) 1994-05-31
HK1006855A1 (en) 1999-03-19
JPH06225765A (ja) 1994-08-16
DE3584209T2 (de) 1995-05-04
JPH10114672A (ja) 1998-05-06
EP0570027A1 (de) 1993-11-18
DE3588219D1 (de) 2000-02-03
US5840304A (en) 1998-11-24
JPH1146779A (ja) 1999-02-23
JPH10210992A (ja) 1998-08-11

Similar Documents

Publication Publication Date Title
DE3584209D1 (de) T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide.
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
DE69737682D1 (de) Gene von moraxella, die für transferrin-rezeptoren kodieren.
ATE76428T1 (de) Expression und sekretion von polypeptiden in eukaryoten unter kontrolle eines adenoviruspromotors.
ZA822855B (en) Bacillus cloning vectors,recombinant dna molecules,bacillus hosts transformed with them and methods for expressing foreign dna sequences and producing polypeptides coded thereby
DE69024291T2 (de) Rezeptoren für Tumornekrosisfaktor-alpha und -beta
ZA859437B (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
EP0621874A4 (en) Somatostatin receptors.
ATE378407T1 (de) Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
ATE106940T1 (de) Für das polypeptid des t-zellantigenreceptors kodierende nukleinsäure.
CA2046917A1 (en) Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides
DK454882A (da) Rekombinante dna-klonende vektorer til anvendelse i streptomyces og dermed beslaegtede organismer
DK295188D0 (da) Fibronectinbindende protein og fremgangsmaade til fremstilling heraf
IL83484A (en) Cdna coding for carcinoembryonic antigen
DK460183D0 (da) Funktionelt uafhaengige rekombinante dna-klonende vektorer til anvendelse i streptomyces
DE69026260D1 (de) Induzierbare Expressionsvektoren
DK61583D0 (da) Gen, der koder for procinpreprorelaxin eller dele heraf samt dna-transfervektor omfattende sekvenser svarende hertil
ATE60801T1 (de) Expressionsvektoren fuer alpha-amylase in bacillus subtilis, erhaltene staemme und verfahren zur herstellung von alpha-amylase.
DK198188D0 (da) Rekombinant-dna-kloningsvektorer, der fremkalder spiramycin-resistens
DK577283A (da) Gen kodet for interleukin-2-polypeptid, rekombinant dna baerende dette gen, levende cellelinie indeholdende dette rekombinante dna og fremgangsmaade til fremstilling af interleukin-2 ved anvendelse af denne cellelinie
SE8800981A (sv) A recombinant fusion protein, its use and a recombinant vector
HUP9903075A2 (hu) Sejtciklus ellenőrzőpont gének

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8372 Publication of ep patent withdrawn
8380 Miscellaneous part iii

Free format text: IM HEFT 43/92, SEITE 12066, SP.1: DIE VEROEFFENTLICHUNG IST ZU STREICHEN

8364 No opposition during term of opposition